Pancreatic cancer. The relative importance of neoadjuvant therapy;Pankreaskarzinom: Stellenwert der neoadjuvanten Therapie

Chirurg

Volumn 74, Issue 3, 2003, Pages 202-207

  Beger, H G ^a,b   Poch, B ^a   Schwarz, M ^a   Gansauge, F ^a  

^a Donau und Illertalklinik GmbH   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Neoadjuvant chemotherapy; Neoadjuvant radiochemotherapy; Pancreas cancer

Indexed keywords

CISPLATIN; DIPYRIDAMOLE; FLUOROURACIL; GEMCITABINE; MITOMYCIN C; STREPTOZOCIN; ANTINEOPLASTIC ANTIBIOTIC; ANTINEOPLASTIC ANTIMETABOLITE; FOLINIC ACID; RADIOSENSITIZING AGENT;

BIOLOGY; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; METASTASIS; PANCREAS CANCER; REVIEW; SURVIVAL RATE; ADJUVANT THERAPY; ADULT; CASE CONTROL STUDY; CHILD; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; LYMPH NODE METASTASIS; MORTALITY; MULTIMODALITY CANCER THERAPY; PANCREAS RESECTION; PANCREAS TUMOR; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RADIATION DOSE; TIME;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; CASE-CONTROL STUDIES; CHILD; CISPLATIN; CLINICAL TRIALS; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS; FLUOROURACIL; HUMANS; LEUCOVORIN; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM METASTASIS; PANCREATECTOMY; PANCREATIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; STREPTOZOCIN; TIME FACTORS;

EID: 0038620418     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-003-0627-5     Document Type: Review

References (42)

1. Andrewn-Sandberg A, Westerdahl I, Ihse J (1992) Recurrence after pancreatectomy for pancreatic cancer. Digestion 52:67
2. Beger HG, Gansauge F, Birk D (2001) Lymph node dissection In: Cameron J (ed) Pancreatic cancer. Decker Inc. Hamilton, London, pp 123-132
3. Beger HG, Büchler MW, Friess H (1994) Chirurgische Ergebnisse und Indikation zu adjuvanten Maßnahmen beim Pankreaskarzinom. Chirurg 65:246
4. Beger HG, Gansauge F, Büchler MW, Link KH (1999) Intraarterial adjuvant chemotherapy after pancreaticoduodenectomy for pancreatic cancer significantly reduces the occurrence of liver metastasis. World J Surgery 23:946
5. Birk D, Fortnagel G, Formentini A, Beger HG (1998) Small carcinoma of the pancreas. Factors of prognostic relevance. J Hepatol Biliary Pancreat Surg 23:234
6. Birk D, Fortnagel G, Formentini A, Beger HG (1998) Carcinoma of the pancreas arising from the uncinate process. Br J Surg 85:498
7. Bittner R, Roscher R, Safi F et al. (1989) Prognostic influence of tumor size and lymph node involvement in pancreatic carcinoma. Chirurgie 60:240
8. Bruckner HW, Snady HW, Dalton H et al. (1998) Split course radiotherapy and simultaneous chemotherapy effectively downstage and facilitate resection of unresectable pancreatic cancers. Eigth International Congress on Anti-Cancer Treatment. SOMPS-O 97
9. Cameron JL, Crist DW, Sitzmann JV et al. (1991) Factors influencing survival after pancreaticoduodenectomy for pancreatic cancer. Am J Surg 161:120
10. Crane CH, Janjan NA, Evans DB et al. (2001) Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Pancreatol 29:2
11. Evans DB, Rich TA, Byrd DR et al. (1992) Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 127:1335
12. Geer RJ, Brennan MF (1993) Prognostic indicators for survival after resection of adenocarcinoma of the pancreas. Am J Surg 165:68
13. Harris J, Bruckner H (2001) Adjuvant and neoadjuvant therapies of pancreatic cancer. Int J Pancreatol 29:1
14. Heeckt P, Safi F, Binder T, Büchler M (1992) Free intraperitoneal tumor cells in pancreatic cancer - significance for clinical course and therapy. Chirurgie 78:2485
15. Hermanek P (1991) Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 17:167-172
16. Hoffman JP, Lipsitz S, Pisansky T et al. (1998) Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncology 16:317
17. Hosch SB, Knoefel WT, Metz S et al. (1997) Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 15:154
18. Inoue S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H (1995) Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis. Jpn J Cancer Res 86:626
19. Ishikawa O, Ohigashi H, Sasaki Y (1994) Liver perfusion chemotherapy via both the hepatic artery and portal vein to prevent hepatic metastasis after extended pancreatectomy for adenocarcinoma of the pancreas. Am J Surg 168:361
20. Ishikawa O (1996) Surgial technique, curability and postoperative quality of life in an extended pancreatectomy for adenocarcinoma of the pancreas. Hepatogastroenterolgoy 43:320
21. Jessup JM, Steele C, Mayer RJ et al. (1993) Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg 128:559
22. Jeekel J, Treurniet-Donker AD (1991) Treatment perspectives in locally advanced unresectable pancreatic cancer. Br J Surg 78:1332
23. Juhl H, Kalthoff H, Kruger U et al. (1994) Immunocytologic detection of disseminated tumor cells in the peritoneal cavity and bone marrow in patients with pancreatic carcinoma. Chirurg 65:1111
24. Kayahara M, Nagakawa T, Futagami F et al. (1996) Lymphatic flow and neural plexus invasion associated with carcinoma of the body and tail of the pancreas. Cancer 78:2485
25. Kawarada Y, Yanagisawa K, Isaij S, Mizumoto R (1994) The prevalence of pancreatic cancer lymph node metastasis in Japan and pancreatic cancer categories. Int J Pancreatol 16:101
26. Kim HJ, Czischke K, Murray BF, Donlon KC (2002) Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer? J Gastrointest Surg 6:763
27. Link KH, Gansauge F, Görich J et al. (1997) Palliative and adjuvant regional chemotherapy in pancreatic cancer. Eur J Surg Oncol 23:409
28. Mühling B, Dehnov C, Steiger I et al. (2003) Micrometastasation in pancreatic head cancer: use of polymerase chain reaction for precise tumor staging. (Unpublished data)
29. Nagakawa T, Konishi I, Ueno K et al. (1991) The results and problems of radical surgery for carcinoma of the head of the pancreas. Jpn J Surg 21:262
30. Nagakawa T, Kayahar M, Ohta T et al. (1991) Patterns of neural and plexus extensive invasion of human pancreatic cancer and experimental cancer. Int J Pancreatology 10:113
31. Neoptolemos J, Dunn J, Moffitt D et al. (2000) ESPAC-1 interim results: a European, randomized study to assess the roles of adjuvant chemotherapy (5FU+folinic acid) and adjuvant chemoradiation (40 Gy+5FU) in resectable pancreatic cancer (Abstract). Proc Am Soc Clin Oncol 19:238
32. Pedrazzoli P, Di Carlo V, Dionigi R et al. (1998) Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas. Ann Surg 228:508
33. Pingpank JF, Hoffman JP, Ross EA et al. (2001) Effect of preoperative chemoradiotherapy on surgical margin status of reseted adenocarcinoma of the head of the pancreas. J Gastrointest Surg 121:121
34. Pisters P, Abbruzzese JL, Janjan NA et al. (1998) Rapid fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adeno carcinoma. J Clin Oncol 16:3843
35. Povoski SP, Karpeh MS, Conlon KC et al. (1999) Association of preoperative biliary drainage with postoperative outcome following pancreaticoduodenectomy. Ann Surg 230:131
36. Rich TA, Lokisch JJ, Chaffey JT et al. (1985) A pilot study of protacted infusion of 5-flourouracil and concomitant radiation therapy. J Clin Oncol 3:402
37. Snady H, Bruckner H, Cooperman A et al. (2000) Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. Cancer 89:314
38. Spitz F, Abbruzzese J, Janjan N et al. (1997) Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 15:928
39. Takahashi S, Ogata Y, Tsuzuki T (1994) Combined resection of the pancreas and portal vein for pancreatic cancer. Br J Surg 81:1190
40. Todd K, Gloor B, Lane J, Reber H (1998) Resection of locally advanced pancreatic cancer after downstaging with continuous-infusion 5-fluorouracil, mitomycin-C, leucovorin and dipyridamole. J Gastrointest Surg 2:159
41. Tsuchiya R, Oribe T, Noda T (1985) Size of the tumor and other factors influencing prognosis of carcinoma of the head of the pancreas. Am J Gastroenterol 80:459
42. Yeo C, Abrams R, Grochow L et al. (1997) Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 225:621